1929 related articles for article (PubMed ID: 28920958)
1. The N
Vu LP; Pickering BF; Cheng Y; Zaccara S; Nguyen D; Minuesa G; Chou T; Chow A; Saletore Y; MacKay M; Schulman J; Famulare C; Patel M; Klimek VM; Garrett-Bakelman FE; Melnick A; Carroll M; Mason CE; Jaffrey SR; Kharas MG
Nat Med; 2017 Nov; 23(11):1369-1376. PubMed ID: 28920958
[TBL] [Abstract][Full Text] [Related]
2. METTL14 Inhibits Hematopoietic Stem/Progenitor Differentiation and Promotes Leukemogenesis via mRNA m
Weng H; Huang H; Wu H; Qin X; Zhao BS; Dong L; Shi H; Skibbe J; Shen C; Hu C; Sheng Y; Wang Y; Wunderlich M; Zhang B; Dore LC; Su R; Deng X; Ferchen K; Li C; Sun M; Lu Z; Jiang X; Marcucci G; Mulloy JC; Yang J; Qian Z; Wei M; He C; Chen J
Cell Stem Cell; 2018 Feb; 22(2):191-205.e9. PubMed ID: 29290617
[TBL] [Abstract][Full Text] [Related]
3. Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia.
Yankova E; Blackaby W; Albertella M; Rak J; De Braekeleer E; Tsagkogeorga G; Pilka ES; Aspris D; Leggate D; Hendrick AG; Webster NA; Andrews B; Fosbeary R; Guest P; Irigoyen N; Eleftheriou M; Gozdecka M; Dias JML; Bannister AJ; Vick B; Jeremias I; Vassiliou GS; Rausch O; Tzelepis K; Kouzarides T
Nature; 2021 May; 593(7860):597-601. PubMed ID: 33902106
[TBL] [Abstract][Full Text] [Related]
4. Promoter-bound METTL3 maintains myeloid leukaemia by m
Barbieri I; Tzelepis K; Pandolfini L; Shi J; Millán-Zambrano G; Robson SC; Aspris D; Migliori V; Bannister AJ; Han N; De Braekeleer E; Ponstingl H; Hendrick A; Vakoc CR; Vassiliou GS; Kouzarides T
Nature; 2017 Dec; 552(7683):126-131. PubMed ID: 29186125
[TBL] [Abstract][Full Text] [Related]
5. [Methyltransferase-like 3 Promotes the Proliferation of Acute Myeloid Leukemia Cells by Regulating N6-methyladenosine Levels of MYC].
Wang XS; He JR; Yu S; Yu J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2018 Jun; 40(3):308-314. PubMed ID: 29978784
[TBL] [Abstract][Full Text] [Related]
6. N
Cheng Y; Xie W; Pickering BF; Chu KL; Savino AM; Yang X; Luo H; Nguyen DT; Mo S; Barin E; Velleca A; Rohwetter TM; Patel DJ; Jaffrey SR; Kharas MG
Cancer Cell; 2021 Jul; 39(7):958-972.e8. PubMed ID: 34048709
[TBL] [Abstract][Full Text] [Related]
7. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.
Li J; Xie H; Ying Y; Chen H; Yan H; He L; Xu M; Xu X; Liang Z; Liu B; Wang X; Zheng X; Xie L
Mol Cancer; 2020 Oct; 19(1):152. PubMed ID: 33121495
[TBL] [Abstract][Full Text] [Related]
8. Stage-specific requirement for Mettl3-dependent m
Lee H; Bao S; Qian Y; Geula S; Leslie J; Zhang C; Hanna JH; Ding L
Nat Cell Biol; 2019 Jun; 21(6):700-709. PubMed ID: 31061465
[TBL] [Abstract][Full Text] [Related]
9. Adipogenic Mesenchymal Stromal Cells from Bone Marrow and Their Hematopoietic Supportive Role: Towards Understanding the Permissive Marrow Microenvironment in Acute Myeloid Leukemia.
Le Y; Fraineau S; Chandran P; Sabloff M; Brand M; Lavoie JR; Gagne R; Rosu-Myles M; Yauk CL; Richardson RB; Allan DS
Stem Cell Rev Rep; 2016 Apr; 12(2):235-44. PubMed ID: 26649729
[TBL] [Abstract][Full Text] [Related]
10. The m
Sang L; Wu X; Yan T; Naren D; Liu X; Zheng X; Zhang N; Wang H; Li Y; Gong Y
J Cancer; 2022; 13(3):1019-1030. PubMed ID: 35154467
[TBL] [Abstract][Full Text] [Related]
11. The Role of RNA Methyltransferase
Wu X; Ye W; Gong Y
Front Oncol; 2022; 12():873903. PubMed ID: 35574332
[TBL] [Abstract][Full Text] [Related]
12. METTL3 mediates bone marrow mesenchymal stem cell adipogenesis to promote chemoresistance in acute myeloid leukaemia.
Pan ZP; Wang B; Hou DY; You RL; Wang XT; Xie WH; Huang HF
FEBS Open Bio; 2021 Jun; 11(6):1659-1672. PubMed ID: 33932138
[TBL] [Abstract][Full Text] [Related]
13. Dynamic m
Yang F; Jin H; Que B; Chao Y; Zhang H; Ying X; Zhou Z; Yuan Z; Su J; Wu B; Zhang W; Qi D; Chen D; Min W; Lin S; Ji W
Oncogene; 2019 Jun; 38(24):4755-4772. PubMed ID: 30796352
[TBL] [Abstract][Full Text] [Related]
14. Discovery of a PROTAC degrader for METTL3-METTL14 complex.
Du W; Huang Y; Chen X; Deng Y; Sun Y; Yang H; Shi Q; Wu F; Liu G; Huang H; Ding J; Huang X; Xu S
Cell Chem Biol; 2024 Jan; 31(1):177-183.e17. PubMed ID: 38194973
[TBL] [Abstract][Full Text] [Related]
15. METTL3 Modulates Osteoclast Differentiation and Function by Controlling RNA Stability and Nuclear Export.
Li D; Cai L; Meng R; Feng Z; Xu Q
Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32121289
[TBL] [Abstract][Full Text] [Related]
16. Deletion of Mettl3 in mesenchymal stem cells promotes acute myeloid leukemia resistance to chemotherapy.
Liao X; Cai D; Liu J; Hu H; You R; Pan Z; Chen S; Xu K; Dai W; Zhang S; Lin X; Huang H
Cell Death Dis; 2023 Dec; 14(12):796. PubMed ID: 38052820
[TBL] [Abstract][Full Text] [Related]
17. Tumor-suppressive MEG3 induces microRNA-493-5p expression to reduce arabinocytosine chemoresistance of acute myeloid leukemia cells by downregulating the METTL3/MYC axis.
Wang A; Chen Y; Shi L; Li M; Li L; Wang S; Wang C
J Transl Med; 2022 Jun; 20(1):288. PubMed ID: 35761379
[TBL] [Abstract][Full Text] [Related]
18. YBX1 is required for maintaining myeloid leukemia cell survival by regulating BCL2 stability in an m6A-dependent manner.
Feng M; Xie X; Han G; Zhang T; Li Y; Li Y; Yin R; Wang Q; Zhang T; Wang P; Hu J; Cheng Y; Gao Z; Wang J; Chang J; Cui M; Gao K; Chai J; Liu W; Guo C; Li S; Liu L; Zhou F; Chen J; Zhang H
Blood; 2021 Jul; 138(1):71-85. PubMed ID: 33763698
[TBL] [Abstract][Full Text] [Related]
19. Mettl3-mediated m
Xu B; Li Q; Wu Y; Wang H; Xu J; Liu H; Xuan A
FASEB J; 2022 Jul; 36(7):e22392. PubMed ID: 35716070
[TBL] [Abstract][Full Text] [Related]
20. A methionine-Mettl3-N
Ramalingam H; Kashyap S; Cobo-Stark P; Flaten A; Chang CM; Hajarnis S; Hein KZ; Lika J; Warner GM; Espindola-Netto JM; Kumar A; Kanchwala M; Xing C; Chini EN; Patel V
Cell Metab; 2021 Jun; 33(6):1234-1247.e7. PubMed ID: 33852874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
